APA (7th ed.) Citation

Y, X., LC, C., YA, Y., ML, C., W, Y., I, D., . . . J, C. (2021). An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity. Cancer immunology research, 9(10), 1141. https://doi.org/10.1158/2326-6066.CIR-21-0058

Chicago Style (17th ed.) Citation

Y, Xu, et al. "An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity." Cancer Immunology Research 9, no. 10 (2021): 1141. https://doi.org/10.1158/2326-6066.CIR-21-0058.

MLA (9th ed.) Citation

Y, Xu, et al. "An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity." Cancer Immunology Research, vol. 9, no. 10, 2021, p. 1141, https://doi.org/10.1158/2326-6066.CIR-21-0058.